Try our Advanced Search for more refined results
7,608,600
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
- June 21, 2017 Fed. Circ. Backs Gilead's Hep C Patent Win Against Idenix
- November 23, 2016 Idenix, Gilead To Battle Over Hepatitis IP At Trial
- January 22, 2016 Info Still Privileged If Atty Worked As Chemist, Idenix Says
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login